BME Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 0.61%, SMA50 1.39%, SMA200 10.29%). The stock’s 14-day RSI is 56.82 (neutral), while the ATR of 0.5 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -0.77% below its high and over 23.76% above its low. Average 10-day trading volume of 44.86 thousand shares is slightly above the 3-month average of 38.65 thousand, indicating heightened recent market interest.

BlackRock Health Sciences Trust last paid a dividend of 3.15 per share, this equals a trailing yield of roughly 7.11%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.35. This means the shares are trading above this model’s fair value.

BlackRock Health Sciences Trust (NYSE:BME) closed at $39.72 USD, losing -$0.51 (-1.27%) from the previous close of $40.23. The stock is currently mid-range between its 52-week high and low $34.18 and $42.74. With a market capitalization of about $513.35 million, BlackRock Health Sciences Trust is classified as a small-cap and shows lower-than-market volatility (beta ~0.60). Key stats such as the average daily volume over the past year has been around 39.32 thousand shares, in line with its 52-week average. Headquartered in New York City, NY, BlackRock Health Sciences Trust operates in the Financial Services sector and the Asset Management industry. BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States.

Our AI price prediction model suggests that BlackRock Health Sciences Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band. Valuation shows BlackRock Health Sciences Trust trading at a premium to the broader market with a P/E of 6.71.

BlackRock Health Sciences Trust trades at a P/E ratio of 6.71, slightly below the S&P 500 average, with a price-to-sales ratio of 19.33 and a price-to-book ratio of 0.91 suggesting the stock is closer to book value. The P/FCF stands at 20.77, also below market averages.